Literature DB >> 33877452

Thoracoscopic repair of congenital diaphragmatic hernia in neonates: findings of a multicenter study in Japan.

Manabu Okawada1, Satoko Ohfuji2, Masaya Yamoto3, Naoto Urushihara3, Keita Terui4, Kouji Nagata5, Tomoaki Taguchi5, Masahiro Hayakawa6, Shoichirou Amari7, Kouji Masumoto8, Tadaharu Okazaki9, Noboru Inamura10, Katsuaki Toyoshima11, Mikihiro Inoue12, Taizo Furukawa13, Akiko Yokoi14, Yutaka Kanamori15, Noriaki Usui16, Yuko Tazuke17, Ryuta Saka17, Hiroomi Okuyama18.   

Abstract

PURPOSE: We compared the efficacy of thoracoscopic repair (TR) with that of open repair (OR) for neonatal congenital diaphragmatic hernia (CDH).
METHODS: The subjects of this multicenter retrospective cohort study were 524 infants with left-sided isolated CDH, diagnosed prenatally, and treated at one of 15 participating hospitals in Japan between 2006 and 2018. The outcomes of infants who underwent TR and those who underwent OR were compared, applying propensity score matching.
RESULTS: During the study period, 57 infants underwent TR and 467 underwent OR. Ten of the infants who underwent TR required conversion to OR for technical difficulties and these patients were excluded from the analysis. The survival rate at 180 days was similar in both groups (TR 98%; OR 93%). Recurrence developed after TR in 3 patients and after OR in 15 patients (TR 7%, OR 3%, p = 0.40). The propensity score was calculated using the following factors related to relevance of the surgical procedure: prematurity (p = 0.1), liver up (p < 0.01), stomach position (p < 0.01), and RL shunt (p = 0.045). After propensity score matching, the multivariate analysis adjusted for severity classification and age at surgical treatment revealed a significantly shorter hospital stay (odds ratio 0.50) and a lower incidence of chronic lung disease (odds ratio 0.39) in the TR group than in the OR group.
CONCLUSIONS: TR can be performed safely for selected CDH neonates with potentially better outcomes than OR.
© 2021. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Congenital diaphragmatic hernia (CDH); Open repair; Thoracoscopic repair

Mesh:

Year:  2021        PMID: 33877452     DOI: 10.1007/s00595-021-02278-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  1 in total

1.  Risk factors for the recurrence of the congenital diaphragmatic hernia-report from the long-term follow-up study of Japanese CDH study group.

Authors:  Kouji Nagata; Noriaki Usui; Keita Terui; Hajime Takayasu; Keiji Goishi; Masahiro Hayakawa; Yuko Tazuke; Akiko Yokoi; Hiroomi Okuyama; Tomoaki Taguchi
Journal:  Eur J Pediatr Surg       Date:  2014-12-19       Impact factor: 2.191

  1 in total
  4 in total

Review 1.  Congenital diaphragmatic hernia.

Authors:  Augusto Zani; Wendy K Chung; Jan Deprest; Matthew T Harting; Tim Jancelewicz; Shaun M Kunisaki; Neil Patel; Lina Antounians; Pramod S Puligandla; Richard Keijzer
Journal:  Nat Rev Dis Primers       Date:  2022-06-01       Impact factor: 52.329

2.  Long-Term Outcomes of Congenital Diaphragmatic Hernia: Report of a Multicenter Study in Japan.

Authors:  Masaya Yamoto; Kouji Nagata; Keita Terui; Masahiro Hayakawa; Hiroomi Okuyama; Shoichiro Amari; Akiko Yokoi; Kouji Masumoto; Tadaharu Okazaki; Noboru Inamura; Katsuaki Toyoshima; Yuhki Koike; Yuta Yazaki; Taizo Furukawa; Noriaki Usui
Journal:  Children (Basel)       Date:  2022-06-08

3.  Impact of the COVID-19 pandemic on congenital diaphragmatic hernia patients: a single-center retrospective study.

Authors:  Yun-Long Zhao; Ying Wang; Chao Liu; Yu-Lin Jiang; Yan-Dong Wei; Hua Meng; Shan Jian; Xi-Ting Zhu; Li-Jian Pei; Xiao-Chen Bai; Feng Feng; Yan Lv; Xi-Ya Zhou; Qing-Wei Qi; Jing-Na Li; Wei Ji; Li-Shuang Ma
Journal:  Pediatr Surg Int       Date:  2022-06-07       Impact factor: 2.003

4.  Recurrence of Congenital Diaphragmatic Hernia: Risk Factors, Management, and Future Perspectives.

Authors:  Francesco Macchini; Genny Raffaeli; Ilaria Amodeo; Martina Ichino; José Luis Encinas; Leopoldo Martinez; Lucas Wessel; Giacomo Cavallaro
Journal:  Front Pediatr       Date:  2022-02-09       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.